Emmessar Biotech & Nutrition submits copy of revised financial results

26 Dec 2015

Emmessar Biotech & Nutrition has submitted a copy of the Revised Financial Results for the period ended September 30, 2015 with the necessary corrections duly done in Profit Before Tax in the Segment wise section.

The above information is a part of company’s filings submitted to BSE.

 

 

 

Related Emmessar Biotech & Nutrition Ltd. Links:

Emmessar Biotech&Nut Share Price

21.53 1.02 (4.97%) Nov 24, 18:57
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 519.90
Dr. Reddys Lab 4910.95
Lupin 895.20
Piramal Enterprises 1423.95
Cadila Healthcare 429.10
View more..
Sensex vs Emmessar Biotech&Nut
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback